TIGIT
Rocheās TIGIT Therapy: ESMO Reveals Ongoing Commitment
Anika Sharma
Roche is taking a steadfast position in the realm of TIGIT-class therapies, even in the face of fluctuating data and ...
Novartis gives up on tislelizumab, BeiGeneās PD-1 inhibitor approved in Europe
Anika Sharma
Novartis has terminated its significant cancer immunotherapy collaboration with BeiGene, ending a partnership that had granted Novartis co-development and co-commercialization ...
Roche Unveils Interim TIGIT Overall Survival Data Following Unintended Release, Triggering Surge in Stocks
Anika Sharma
An unexpected revelation has provided the world with a sneak peek into Roche’s highly anticipated TIGIT data. Roche, which had ...
